| Financial Year |
March 31 2023 |
| Monetary Funds |
296,415,642.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
50,905,972.21 |
| Advances to Suppliers |
8,197,738.32 |
| Other Receivables |
1,343,577.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
117,621,922.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,666,238.42 |
| Total Current Assets |
508,170,893.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
250,966,219.59 |
| Investment Properties |
1,200,911.26 |
| Fixed Assetes |
718,448,900.35 |
| Under-construction Projects |
213,424,403.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,718,038.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,295,609.81 |
| Deferred Income Tax Assets |
14,707,381.94 |
| Other Non-Current Assets |
37,943,569.25 |
| Sub-Total of Non-Current Assets |
1,307,545,939.73 |
| Total Assets |
1,815,716,832.96 |
| Short-Term Loans |
173,602,852.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
58,167,435.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,722,140.69 |
| Taxes Payable |
3,545,274.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,524,564.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,007,305.44 |
| Other Current Liabilities |
766,099.47 |
| Sub-Total of Current Liabilities |
328,007,093.25 |
| Long-term Loans |
319,716,017.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,143,291.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
357,153,923.61 |
| Total Liabilities |
685,161,016.86 |
| Paid-In Capital(Or Share Stock) |
233,788,800.00 |
| Capital Surplus |
236,514,007.16 |
| Surplus Reserve |
104,074,443.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
553,030,565.36 |
| Minority Stockholder's Interest |
2,919,612.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,127,636,203.30 |
| Owner's Equity（Stockholder's Equity） |
1,130,555,816.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,815,716,832.96 |
